InvestorsObserver
×
News Home

Is McKesson Corp (MCK) a Good Choice in Medical Distribution Monday?

Monday, November 27, 2023 12:40 PM | InvestorsObserver Analysts

Mentioned in this article

Is McKesson Corp (MCK) a Good Choice in Medical Distribution Monday?

The 78 rating InvestorsObserver gives to McKesson Corp (MCK) stock puts it near the top of the Medical Distribution industry. In addition to scoring higher than 88 percent of stocks in the Medical Distribution industry, MCK’s 78 overall rating means the stock scores better than 78 percent of all stocks.

Overall Score - 78
MCK has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on MCK!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With McKesson Corp Stock Today?

McKesson Corp (MCK) stock has gained 0.64% while the S&P 500 has fallen -0.1% as of 12:23 PM on Monday, Nov 27. MCK has gained $2.94 from the previous closing price of $461.07 on volume of 431,547 shares. Over the past year the S&P 500 is up 14.91% while MCK has gained 22.00%. MCK earned $25.31 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 18.29. Click Here to get the full Stock Report for McKesson Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App